The GLP is committed to full transparency. Download and review our 2019 Annual Report

Bayer’s deal to buy Monsanto may face scrutiny back home in Germany

The GLP posts this article or excerpt as part of a daily curated selection of biotechnology-related news, opinion and analysis.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Bayer faces a backlash against Germany’s biggest planned acquisition because of two products from the St. Louis-based company that are widely detested in the country: genetically modified seeds and the weedkiller Roundup…

“Germans view Monsanto as the main example of American corporate evil,” said Heike Moldenhauer, a biotechnology expert at German environmental group BUND. “It may not be such a good idea to take over Monsanto as that means incorporating its bad reputation, which would also make Bayer more vulnerable.”

A German Environment Ministry study released last month found 75 percent of citizens are against genetic engineering…

Related article:  California's Prop 65 listing of herbicide glyphosate as carcinogen goes into effect July 7


Several German hardware store chains… stopped selling products using glyphosate last year in the wake of a report from the World Health Organization’s International Agency for Research on Cancer…


Bayer’s plan “is a wrong signal for Germany and environmental protection,” [Renate Kuenast, Germany’s former agriculture minister] said in an e-mail. “Monsanto stands for glyphosate and agricultural bio-engineering and thus for a loss of biodiversity and good soils. It’s a folly we need to stop.”

Read full, original post: Bayer’s mega Monsanto deal faces mega backlash in Germany

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend